slotkoers
Palestine Exchange
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
- JOD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
97,67
|
101,3
|
102,6
|
109,5
|
171
|
169,4
|
Bedrijfswaarde
1 |
88,09
|
91,77
|
93,12
|
97,74
|
155,5
|
152,2
|
K/w-verhouding
|
12,4
x
|
10,6
x
|
13,9
x
|
9,07
x
|
21,5
x
|
27,3
x
|
Dividendrendement
|
2,92%
|
4,13%
|
2,78%
|
1,77%
|
2,27%
|
-
|
Marktkapitalisatie/omzet
|
2,75
x
|
2,93
x
|
2,86
x
|
2,41
x
|
3,63
x
|
3,93
x
|
Bedrijfswaarde/omzet
|
2,48
x
|
2,65
x
|
2,6
x
|
2,15
x
|
3,31
x
|
3,53
x
|
Bedrijfswaarde/EBITDA
|
9,56
x
|
9,72
x
|
10,9
x
|
8,16
x
|
13,9
x
|
17,5
x
|
Bedrijfswaarde/FCF
|
32,3
x
|
35,9
x
|
16,7
x
|
-83,7
x
|
-159
x
|
29,2
x
|
FCF Yield
|
3,1%
|
2,79%
|
6%
|
-1,19%
|
-0,63%
|
3,42%
|
Price to Book
|
1,32
x
|
1,3
x
|
1,3
x
|
1,19
x
|
1,67
x
|
1,54
x
|
Aantal aandelen (in duizenden)
|
38.765
|
38.765
|
38.765
|
38.765
|
38.765
|
38.765
|
Referentieprijs
2 |
2,520
|
2,613
|
2,647
|
2,825
|
4,410
|
4,370
|
Datum van publicatie
|
31/03/19
|
5/04/20
|
18/04/21
|
31/03/22
|
29/03/23
|
15/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
35,55
|
34,58
|
35,85
|
45,47
|
47,03
|
43,13
|
EBITDA
1 |
9,212
|
9,437
|
8,568
|
11,98
|
11,22
|
8,676
|
Bedrijfsresultaat (EBIT)
1 |
7,641
|
7,828
|
6,882
|
10,31
|
9,559
|
7,18
|
Operationele Marge
|
21,5%
|
22,64%
|
19,19%
|
22,68%
|
20,32%
|
16,65%
|
Resultaat voor belastingen (EBT)
1 |
8,808
|
10,29
|
8,151
|
13,38
|
9,024
|
7
|
Nettowinst (verlies)
1 |
7,904
|
9,525
|
7,369
|
12,08
|
7,947
|
6,116
|
Nettomarge
|
22,24%
|
27,55%
|
20,55%
|
26,56%
|
16,9%
|
14,18%
|
WPA
2 |
0,2039
|
0,2457
|
0,1901
|
0,3116
|
0,2050
|
0,1600
|
Free Cash Flow
1 |
2,727
|
2,556
|
5,585
|
-1,167
|
-0,979
|
5,212
|
FCF-marge
|
7,67%
|
7,39%
|
15,58%
|
-2,57%
|
-2,08%
|
12,09%
|
Kasstroomconversie (ebitda)
|
29,61%
|
27,09%
|
65,19%
|
-
|
-
|
60,08%
|
Kasstroomconversie (nettowinst)
|
34,51%
|
26,84%
|
75,79%
|
-
|
-
|
85,23%
|
Dividend per aandeel
2 |
0,0735
|
0,1078
|
0,0735
|
0,0500
|
0,1000
|
-
|
Datum van publicatie
|
31/03/19
|
5/04/20
|
18/04/21
|
31/03/22
|
29/03/23
|
15/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
9,58
|
9,51
|
9,49
|
11,8
|
15,4
|
17,2
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2,73
|
2,56
|
5,59
|
-1,17
|
-0,98
|
5,21
|
ROE (netto-inkomsten/eigen vermogen)
|
11,3%
|
12,6%
|
9,31%
|
14,1%
|
8,08%
|
5,9%
|
ROA (netto-inkomsten/totale activa)
|
5,59%
|
5,2%
|
4,36%
|
6,11%
|
5,09%
|
3,62%
|
Totale activa
1 |
141,3
|
183,3
|
168,9
|
197,7
|
156,3
|
169,1
|
Nettoactief per aandeel
2 |
1,900
|
2,010
|
2,030
|
2,370
|
2,650
|
2,840
|
Cashflow per aandeel
2 |
0,0500
|
0,1300
|
0,0700
|
0,0300
|
0,0800
|
0,0800
|
Capex
1 |
2,83
|
4,22
|
0,5
|
0,93
|
3,59
|
3,33
|
Capex/omzet
|
7,95%
|
12,2%
|
1,4%
|
2,04%
|
7,63%
|
7,73%
|
Datum van publicatie
|
31/03/19
|
5/04/20
|
18/04/21
|
31/03/22
|
29/03/23
|
15/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +21,63% | 44,11 mld. | | +23,03% | 22,71 mld. | | +18,22% | 15,15 mld. | | +12,66% | 13,56 mld. | | +60,18% | 12,7 mld. | | -10,02% | 6,84 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +12,92% | 5,63 mld. |
Generieke geneesmiddelen
|